Bharat Biotech concludes final analysis for COVAXIN, claims 77.8 pc efficacy from phase-3 clinical trials
Hyderabad, Jul 3 (UNI): Bharat Biotech, a global leader in vaccine development and innovation, announced on Saturday safety and efficacy ...
Hyderabad, Jul 3 (UNI): Bharat Biotech, a global leader in vaccine development and innovation, announced on Saturday safety and efficacy ...
Demonstrating its scientific commitment to data generation and data transparency, Bharat Biotech shared full data of all research studies of ...
In all 30 children, aged 12-18, were administered Covaxin at Mysuru Medical College and Research Institute (MMCRI) as part of ...
Hyderabad-based Bharath Biotech which has received permission to carry out pediatric trials of the Covid vaccine Covaxin, will commence its ...
Zimbabwe becomes the first African country to authorize use of COVID 19 vaccine ‘COVAXIN’. Zimbabwe has reported over 36,000 coronavirus ...
Bharat Biotech, a global leader in vaccine innovation, developing vaccines for infectious diseases, today announced the first interim analysis of ...
Bharat Biotech International Ltd. has signed an agreement with Brazil for the supply of 20 million doses of Covaxin vaccine. ...
Bharat Biotech has secured a fresh Letter of Comfort from the Centre for another 45 lakh doses of its COVID-19 ...
Bharat Biotech, which has received a government purchase order for supply of 55 lakh doses of Covaxin, a COVID-19 vaccine, ...
New Delhi: The Bharat BioTech on Friday sent a request to DCGI seeking permission for conducting the trials of the ...
© Janam Multimedia Limited